$ESS

ESS Inc highlights sodium-ion BESS deployment, reports net losses in Q2 2026 financials

ESS Inc reported Q2 2026 adjusted net losses of $7.9 million, versus $7.8 million a year earlier. Unrestricted cash was $5.6 million at July 31, 2026. CEO Drew Buckley said ESS is expanding sodium-ion BESS, including an April LOI with Alsym Energy and a July LOI with Juniper Energy. ESS also cited prior contracts and a proposed business combination.

Original reporting
Published Aug 13, 2026, 10:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 10:38 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
ESS Inc highlights sodium-ion BESS deployment, reports net losses in Q2 2026 financials — source image
Decision brief

The 30-second read

$ESSNeutralMed
01

Why it matters

Traders can reassess ESS’s commercialization credibility and financing risk using the new Q2 2026 financial datapoints (losses, cash, operating expense growth) and the newly detailed sodium-ion partnership pipeline (Alsym cell/module additions and Juniper deployment LOI).

02

Market read

Fresh financials plus specific sodium-ion deployment LOI details can move ESS’s valuation narrative, but the lack of signed revenue contracts keeps execution and cash-burn risk central.

03

What to watch

The article cites a Bridge modular rollout and thermal-runaway claims, but provides no validation metrics, procurement timelines, or signed capacity purchase agreements that would de-risk execution.

Relevance 6/10Novelty 6/10Timing: today’s release of Q2 2026 financials and LOI updates

Background

ESS is a NYSE-listed energy storage company that has been pursuing alternative battery technologies, including sodium-ion, alongside other systems like iron flow.

Company-level read

Ticker impact

$ESSNeutralMedium confidence
Context

ESS reports Q2 2026 adjusted losses and highlights sodium-ion BESS expansion via LOIs with Alsym Energy and Juniper Energy.

Expected impact

Near-term trading likely hinges on whether investors view the LOIs and Bridge rollout as credible revenue conversion versus continued cash burn.

Evidence & confidence

New facts include Q2 2026 loss figures, cash levels, and specific LOI details (Alsym cell/module add-on and Juniper deployment scale). However, the text does not provide signed contracts or revenue booked from these initiatives, limiting immediate fundamental certainty.

Market effects

Reinforces momentum in sodium-ion BESS commercialization narratives, potentially supporting sentiment for alternative battery chemistries versus lithium-ion.

US-focused deployment plans (data centers, critical infrastructure, utility markets, and California projects) keep the catalyst concentrated in US grid and renewables supply chains.

Limited direct global read-through because the disclosed partnerships and deployments are US-centric and early-stage.

Counterpoint

LOIs and early-stage opportunities may not translate into revenue quickly, while operating cash burn remains heavy, keeping dilution or financing risk elevated.

Key entities

  • ESS Inc

    NYSE-listed energy storage company reporting Q2 2026 financials and sodium-ion BESS expansion via LOIs.

  • Alsym Energy

    US sodium-ion battery startup referenced in ESS’s April LOI and cell/module supply expansion.

  • Juniper Energy

    California-based renewables developer referenced in ESS’s July LOI for Na-ion BESS deployments.

  • Salt River Project (SRP)

    Utility partner in ESS’s Project New Horizon collaboration with Google for a 5MW/50MWh iron flow system.

  • Google

    Tech giant referenced as a partner in ESS’s Project New Horizon collaboration.

Related articles

$AVBMedAI 8/10

Vivmark Details Merged Entity, Becomes Largest U.S. Apartment REIT By Far

Vivmark Residential, formed from the merger of AvalonBay Communities and Equity Residential, will launch Tuesday on the NYSE with about $54B equity market cap and $70B enterprise value. It will own 634 apartment communities with 184,000+ units, plus 11,100 under construction. The company targets $125M synergies over 18 months.

$ESSMedAI 8/10

Essex Property Trust (ESS) Q2 2026 Earnings Call Transcript

Essex Property Trust (ESS) discussed Q2 2026 results and updated guidance on an earnings call. Core FFO per share exceeded the guidance midpoint by $0.10. The company raised full-year core FFO per share guidance midpoint by $0.20 (1.3%) and lifted same-property NOI growth to 2.8%. Q3 core FFO guidance midpoint is $3.99. Net debt-to-EBITDA is 5.4x.

$MAAMed

Multifamily REITs Grow More Optimistic on Apartment Recovery

Multifamily REIT executives said renter demand is holding up as new apartment supply begins to peak, citing stronger absorption and moderating deliveries on Q2 earnings calls. MAA highlighted resilient demand and declining deliveries. AvalonBay and Equity Residential proposed a merger. Camden sold a 11-community California portfolio for about $1.62B. Q2 core FFO per share: AVB $2.86, CPT $1.68, ELS $1.00, MAA $2.08, UDR $0.60, ES $4.08, UDR $0.60, CPC $1.27.

$ESSLow

Essex Property (ESS) Trust Gets Higher Price Target from Truist

On May 27, Truist raised its price target for Essex Property Trust (NYSE:ESS) to $286 from $273 and kept a Hold rating, citing updated assumptions of $300M in 2026 acquisitions and $75M in dispositions. On May 15, Scotiabank increased its target to $282 from $278 and maintained Outperform, expecting a slower Sunbelt recovery but citing ESS’s Northern California exposure.

$ESSMed

Legal & General Group Plc Raises Stake in Essex Property Trust, Inc. $ESS

Legal & General Group Plc increased its stake in Essex Property Trust (NYSE:ESS) by 3.2% in Q4, buying 29,466 shares to hold 950,748 shares, worth $248.8 million, according to its SEC filing. The REIT reported Q1 EPS of $1.65 vs $3.96 expected on revenue of $484.8 million. Essex set Q2 2026 guidance at 3.920–4.040 EPS and declared a $2.59 quarterly dividend.

$ESSMedAI 8/10

JPMorgan Raises its Price Target on Essex Property Trust (ESS)

On May 18, 2026, JPMorgan analyst Anthony Paolone raised Essex Property Trust’s (ESS) price target to $275 from $272 but kept an Underweight rating, citing a slower Sunbelt recovery tied to oversupply. Scotiabank lifted its target to $282 (Outperform) and Cantor Fitzgerald to $291 (Overweight). Essex reported Q1 FFO of $4.06/share vs $3.96 consensus, with same-property revenue up 2.9% and NOI up 4.1%.